Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726571 | SCV000345595 | uncertain significance | not provided | 2016-08-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000305282 | SCV000535176 | likely benign | not specified | 2016-12-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001088071 | SCV000560864 | benign | Duchenne muscular dystrophy | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537617 | SCV004740642 | likely benign | DMD-related disorder | 2019-09-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000726571 | SCV001743716 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000726571 | SCV001931035 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001833414 | SCV002087835 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2017-11-16 | no assertion criteria provided | clinical testing |